Donor-Derived CD123-Targeted CAR T Cell Serves as a RIC Regimen for Haploidentical Transplantation in a Patient With FUS-ERG+ AML
Background: Allogeneic hematopoietic stem cell transplantation (allo-HSCT) following chemotherapy is part of standard treatment protocol for patients with acute myeloid leukemia (AML). FUS-ERG+ AML is rare but has an extremely poor prognosis even with allo-HSCT in remission, possibly due to its a le...
Main Authors: | Sun Yao, Chen Jianlin, Liu Yarong, Li Botao, Wang Qinghan, Fang Hongliang, Zhang Lu, Ning Hongmei, Wang Pin, Chen Hu, Hu Liangding, Zhang Bin |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-12-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2019.01358/full |
Similar Items
-
Evaluation of switch-mediated costimulation in trans on universal CAR-T cells (UniCAR) targeting CD123-positive AML
by: Jan-Erik Meyer, et al.
Published: (2021-01-01) -
IFN-γ and TNF-α aggravate endothelial damage caused by CD123-targeted CAR T cell
by: Sun Y, et al.
Published: (2019-06-01) -
Quimerismo molecular en el trasplante alogénico de células hematopoyéticas: Resultados preliminares Molecular chimerism in the allogeneic transplantation of hematopoietic cells: Preliminary results
Published: (2005-12-01) -
Novel CD123 polyaptamer hydrogel edited by Cas9/sgRNA for AML-targeted therapy
by: Haibin Wu, et al.
Published: (2021-01-01) -
CD123 Is Consistently Expressed on <i>NPM1</i>-Mutated AML Cells
by: Vincenzo Maria Perriello, et al.
Published: (2021-01-01)